Stem cells from umbilical cord blood is preserved as it has capabilities of regenerating into any type of body cells. In life threatening malignant and non-malignant diseases, hematopoietic stem cells transplantation (HSCT) can help in saving the life of person. In addition, the therapy is comparatively cost effective and has limited side effects. Umbilical stem cells are used for treating cancer, blood diseases like anemia and certain immune system disorders.MARKET DYNAMICS
The stem cell umbilical cord blood (UCB) market is anticipated to grow in the forecast period owing to increasing occurrence of chronic diseases as well as rising support of government and private sector for research and development. In addition, the growing popularity for umbilical cord storage in developing countries is expected to create opportunities for market growth during the forecast periodMARKET SCOPE
The "Global Stem Cell Umbilical Cord Blood (UCB) Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of stem cell umbilical cord blood (UCB) market with detailed market segmentation by storage option, disease and geography. The global stem cell umbilical cord blood (UCB) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading stem cell umbilical cord blood (UCB) market players and offers key trends and opportunities in the market.MARKET SEGMENTATION
The global stem cell umbilical cord blood (UCB) market is segmented on the basis of storage option, disease. Based on storage option, the market is bifurcated into private UCB banks and public UCB banks. On the basis of disease, the market is classified as bone marrow failure syndrome, immune deficiencies, leukemia, lymphoma, metabolic/storage diseases and other diseases.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stem cell umbilical cord blood (UCB) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stem cell umbilical cord blood (UCB) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting stem cell umbilical cord blood (UCB) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the stem cell umbilical cord blood (UCB) market in these regions.MARKET PLAYERS
The reports cover key developments in the stem cell umbilical cord blood (UCB) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from stem cell umbilical cord blood (UCB) market are anticipated to lucrative growth opportunities in the future with the rising demand for stem cell umbilical cord blood (UCB) market in the global market. Below mentioned is the list of few companies engaged in the stem cell umbilical cord blood (UCB) market.
The report also includes the profiles of key stem cell umbilical cord blood (UCB) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- CBR Systems, Inc.
- Cordlife Sciences India Pvt. Ltd.
- Cryo-Cell International, Inc.
- Cryoviva India
- Global Cord Blood Corporation
- Regrow Biosciences Pvt. Ltd.
- Smart Cells International Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.